# DOXORUBICIN HYDROCHLORIDE

NDC: 68001-704
Generic name: doxorubicin hydrochloride
Labeler / Manufacturer: BluePoint Laboratories
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTABLE, LIPOSOMAL
Routes: INTRAVENOUS
Marketing started: 20260402

FDA application: ANDA212299

## Active ingredients

- DOXORUBICIN HYDROCHLORIDE: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68001-704"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68001-704
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ada390ce-50ea-4de5-be58-5b03caf33c23